Logo image of HI.MI

HEALTH ITALIA SPA (HI.MI) Stock Fundamental Analysis

BIT:HI - Euronext Milan - IT0005585861 - Common Stock - Currency: EUR

281  -1 (-0.35%)

Fundamental Rating

5

Overall HI gets a fundamental rating of 5 out of 10. We evaluated HI against 503 industry peers in the Health Care Providers & Services industry. HI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

HI had positive earnings in the past year.
In the past year HI had a positive cash flow from operations.
HI had positive earnings in each of the past 5 years.
HI had a positive operating cash flow in each of the past 5 years.
HI.MI Yearly Net Income VS EBIT VS OCF VS FCFHI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

With a decent Return On Assets value of 4.16%, HI is doing good in the industry, outperforming 73.08% of the companies in the same industry.
HI's Return On Equity of 6.91% is in line compared to the rest of the industry. HI outperforms 53.85% of its industry peers.
HI's Return On Invested Capital of 5.21% is in line compared to the rest of the industry. HI outperforms 57.69% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HI is significantly below the industry average of 13.71%.
Industry RankSector Rank
ROA 4.16%
ROE 6.91%
ROIC 5.21%
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
HI.MI Yearly ROA, ROE, ROICHI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

HI's Profit Margin of 7.52% is amongst the best of the industry. HI outperforms 92.31% of its industry peers.
HI's Profit Margin has improved in the last couple of years.
HI has a better Operating Margin (12.85%) than 96.15% of its industry peers.
HI's Operating Margin has improved in the last couple of years.
HI's Gross Margin of 33.27% is in line compared to the rest of the industry. HI outperforms 53.85% of its industry peers.
In the last couple of years the Gross Margin of HI has remained more or less at the same level.
Industry RankSector Rank
OM 12.85%
PM (TTM) 7.52%
GM 33.27%
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
HI.MI Yearly Profit, Operating, Gross MarginsHI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HI is destroying value.
Compared to 1 year ago, HI has more shares outstanding
The number of shares outstanding for HI has been reduced compared to 5 years ago.
Compared to 1 year ago, HI has an improved debt to assets ratio.
HI.MI Yearly Shares OutstandingHI.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
HI.MI Yearly Total Debt VS Total AssetsHI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.02 indicates that HI is not in any danger for bankruptcy at the moment.
HI has a better Altman-Z score (3.02) than 84.62% of its industry peers.
The Debt to FCF ratio of HI is 15.21, which is on the high side as it means it would take HI, 15.21 years of fcf income to pay off all of its debts.
HI has a worse Debt to FCF ratio (15.21) than 69.23% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that HI is not too dependend on debt financing.
HI's Debt to Equity ratio of 0.22 is amongst the best of the industry. HI outperforms 88.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 15.21
Altman-Z 3.02
ROIC/WACC0.68
WACC7.66%
HI.MI Yearly LT Debt VS Equity VS FCFHI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 3.18 indicates that HI has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.18, HI belongs to the top of the industry, outperforming 96.15% of the companies in the same industry.
HI has a Quick Ratio of 3.18. This indicates that HI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.18, HI belongs to the best of the industry, outperforming 96.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.18
Quick Ratio 3.18
HI.MI Yearly Current Assets VS Current LiabilitesHI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.15% over the past year.
The Earnings Per Share has been growing by 181.50% on average over the past years. This is a very strong growth
The Revenue has decreased by -0.86% in the past year.
The Revenue has been growing slightly by 2.37% on average over the past years.
EPS 1Y (TTM)61.15%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%504.86%
Revenue 1Y (TTM)-0.86%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%-10.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HI.MI Yearly Revenue VS EstimatesHI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
HI.MI Yearly EPS VS EstimatesHI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.04, HI is valued on the expensive side.
The rest of the industry has a similar Price/Earnings ratio as HI.
The average S&P500 Price/Earnings ratio is at 26.34. HI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.04
Fwd PE N/A
HI.MI Price Earnings VS Forward Price EarningsHI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as HI.
Based on the Price/Free Cash Flow ratio, HI is valued more expensive than 80.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 88.76
EV/EBITDA 9.87
HI.MI Per share dataHI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The decent profitability rating of HI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.11
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HI!.
Industry RankSector Rank
Dividend Yield N/A

HEALTH ITALIA SPA

BIT:HI (6/13/2025, 7:00:00 PM)

281

-1 (-0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap53.39M
Analysts84.44
Price Target372.3 (32.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-15.12%
PT rev (3m)-15.12%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20.04
Fwd PE N/A
P/S 1.51
P/FCF 88.76
P/OCF 17.44
P/B 1.39
P/tB 1.52
EV/EBITDA 9.87
EPS(TTM)14.02
EY4.99%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.17
FCFY1.13%
OCF(TTM)16.11
OCFY5.73%
SpS186.12
BVpS202.44
TBVpS184.42
PEG (NY)N/A
PEG (5Y)0.11
Profitability
Industry RankSector Rank
ROA 4.16%
ROE 6.91%
ROCE 9.35%
ROIC 5.21%
ROICexc 5.54%
ROICexgc 5.97%
OM 12.85%
PM (TTM) 7.52%
GM 33.27%
FCFM 1.7%
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
ROICexc(3y)7.88%
ROICexc(5y)6.76%
ROICexgc(3y)8.74%
ROICexgc(5y)7.6%
ROCE(3y)12.74%
ROCE(5y)10.6%
ROICexcg growth 3Y-3.65%
ROICexcg growth 5YN/A
ROICexc growth 3Y-1.37%
ROICexc growth 5YN/A
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 15.21
Debt/EBITDA 1.49
Cap/Depr 221.98%
Cap/Sales 6.96%
Interest Coverage 250
Cash Conversion 54.18%
Profit Quality 22.63%
Current Ratio 3.18
Quick Ratio 3.18
Altman-Z 3.02
F-Score7
WACC7.66%
ROIC/WACC0.68
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.15%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%504.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.86%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%-10.1%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.66%
EBIT growth 3Y4.03%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.81%
FCF growth 3YN/A
FCF growth 5Y-21.09%
OCF growth 1Y43.49%
OCF growth 3Y55.79%
OCF growth 5Y-20.58%